taxonomy (5)
protein (32)
source (11)
structure (9)
composition (1)
disease (4)
reference (17)
site (47)
peptide (40)
- Homo sapiens (Human)
- Mus musculus (House mouse)
- Ovis aries (Sheep)
- Torpedo californica (Pacific electric ray)
- Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
Taxonomy
- 4F2 cell-surface antigen heavy chain / Homo sapiens P08195
- Aggrecan core protein / Homo sapiens P16112
- Alpha-1-acid glycoprotein 1 / Homo sapiens P02763
- Alpha-1-acid glycoprotein 2 / Homo sapiens P19652
- Alpha-1-antichymotrypsin / Homo sapiens P01011
- Apolipoprotein (a) / Homo sapiens P08519
- Apolipoprotein d / Homo sapiens P05090
- Coagulation factor IX / Homo sapiens P00740
- Folate receptor alpha / Homo sapiens P15328
- Follitropin, alpha and beta chains / Homo sapiens P01225 P01215
- G-protein coupled receptor 126 / Homo sapiens Q86SQ4
- Glucose-6-phosphate isomerase / Homo sapiens P06744
- Haptoglobin / Homo sapiens P00738
- Immunoglobulin heavy constant mu / Homo sapiens P01871
- Integrin alpha-5/beta-1 / Homo sapiens P05556 P08648
- Kallistatin / Homo sapiens P29622
- Kininogen-1 / Homo sapiens P01042
- Lysosomal acid lipase/cholesteryl ester hydrolase / Homo sapiens P38571
- Lysosome-associated membrane glycoprotein 2 / Homo sapiens P13473
- Multimerin-2 / Homo sapiens Q9H8L6
- Nitrogen permease regulator 3-like protein / Homo sapiens Q12980
- Plasma protease c1 inhibitor / Homo sapiens P05155
- Prostaglandin-h2 d-isomerase / Homo sapiens P41222
- Receptor-type tyrosine-protein phosphatase F / Homo sapiens P10586
- Recombinant plasminogen - [r580e] / Homo sapiens P00750
- Recombinant plasminogen - [r580s] / Homo sapiens P00750
- Uncharacterized protein from Fluid / Homo sapiens
- Uromodulin / Homo sapiens P07911
- V-type proton ATPase subunit S1 / Mus musculus Q9R1Q9
- Alpha-1-acid glycoprotein / Ovis aries W5P7S6
- Acetylcholine receptor protein / Torpedo californica P02712 P02718 P02710 P02714
- Recombinant Spike glycoprotein (HEK293) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) P0DTC2
Protein
- Blood Plasma (UBERON_0001969)
- Blood Serum (UBERON_0001977)
- Brain (UBERON_0000955)
- Electric Organ (UBERON_0006869)
- Mammary Gland (UBERON_0001911)
- Ovary (UBERON_0000992) CHO (CVCL_0213)
- Ovary (UBERON_0000992) Sf21 (CVCL_0518)
- Placenta (UBERON_0001987)
- Pleura (UBERON_0000977) K-562 (CVCL_0004)
- Urine (UBERON_0001088)
- HEK293 (CVCL_0045)
Source
- N-Linked / Complex / Gal(b1-4)GlcNAc(?1-?)[Gal(b1-4)GlcNAc(?1-?)]Man(a1-?)[Gal(b1-4)GlcNAc(?1-?)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ Gal(b1-4)GlcNAc(?1-?) + 4 x NeuAc(a2-?)"
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-6)]Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ 2 x NeuAc(a2-3) + 2 x NeuAc(2-6)"
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-6)]Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ 4 x NeuAc"
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-?)[Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-6)]Man(a1-?)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ 2 x NeuAc(a2-3) + 2 x NeuAc(a2-6)"
- N-Linked / Complex / Structure 775
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-6)]Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ 4 x NeuAc(a2-?)"
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)[NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)[NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-6)]Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)[NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-6)]Man(a1-6)[NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-4)[NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)]Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / NeuAc(a2-?)Gal(b1-4)GlcNAc(b1-2)[NeuAc(a2-?)Gal(b1-4)GlcNAc(b1-6)]Man(a1-?)[NeuAc(a2-?)Gal(b1-4)GlcNAc(b1-4)[NeuAc(a2-?)Gal(b1-4)GlcNAc(b1-2)]Man(a1-?)]Man(b1-4)GlcNAc(b1-4)GlcNAc
Reported structure
- Hex:7 HexNAc:6 NeuAc:4 (avg mass : 3537.2137 )
Composition
- Cancer, breast (DOID:1612)
- COVID-19 (DOID:0080600)
- Leukemia, Myloid, Chronic (DOID:8552)
- Prostate cancer (DOID:10283)
Disease
- Site-specific N-glycosylation Characterization of Recombinant SARS-CoV-2 Spike Proteins using High-Resolution Mass Spectrometry (2020 - Yong Zhang, Wanjun Zhao, Yonghong Mao, Shisheng Wang, Yi Zhong, Tao Su, Meng Gong, Xiaofeng Lu, Jingqiu Cheng, Hao Yang) / Status : Unreviewed
- Capturing site-specific heterogeneity with large-scale N-glycoproteome analysis (2019 - Nicholas M. Riley, Alexander S. Hebert, Michael S. Westphall & Joshua J. Coon ) / Status : Unreviewed
- Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein (2018 - Shisheng Sun, Yingwei Hu, Li Jia, Shadi Toghi Eshghi, Yang Liu, Punit Shah, Hui Zhang) / Status : Unreviewed
- Large-scale intact glycopeptide identification by Mascot database search (2018 - Ravi Chand Bollineni, Christian Jeffrey Koehler, Randi Elin Gislefoss, Jan Haug Anonsen, Bernd Thiede) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Distinct urinary glycoprotein signatures in prostate cancer patients (2018 - Rebeca Kawahara, Fabio Ortega, Livia Rosa-Fernandes, Vanessa Guimarães, Daniel Quina, Willian Nahas, Veit Schwämmle, Miguel Srougi, Katia R.M. Leite, Morten Thaysen-Andersen, Martin R. Larsen and Giuseppe Palmisano) / Status : Unreviewed
- Confident assignment of site-specific glycosylation in complex glycoproteins in a single step (2014 - Khatri K, Staples GO, Leymarie N, Leon DR, Turiák L, Huang Y, Yip S, Hu H, Heckendorf CF, Zaia J.) / Status : Reviewed
- Selective glycopeptide profiling by acetone enrichment and LC/MS (2014 - Takakura D, Harazono A, Hashii N, Kawasaki N) / Status : Reviewed
- Structural analysis of N-linked sugar chains of human blood clotting factor IX. (2000 - Makino Y, Omichi K, Kuraya N, Ogawa H, Nishimura H, Iwanaga S, Hase S) / Status : Reviewed
- Structural determination of N-linked carbohydrates by matrix-assisted laser desorption/ionization-mass spectrometry following enzymatic release within sodium dodecyl sulfate-polyacrylamide electrophoresis gels: application to species-specific glycosylation of alpha1-acid glycoprotein. (1998 - Kuster B, Hunter A, Wheeler S, Dwek R, Harvey D) / Status : Reviewed
- Detailed oligosaccharide structures of human integrin alpha 5 beta 1 analyzed by a three-dimensional mapping technique. (1996 - Nakagawa H, Zheng M, Hakomori S, Tsukamoto Y, Kawamura Y, Takahashi N) / Status : Reviewed
- Detailed structural analysis of asparagine-linked oligosaccharides of the nicotinic acetylcholine receptor from Torpedo californica. (1992 - Shoji H, Takahashi N, Nomoto H, Ishikawa M, Shimada I, Arata Y, Hayashi K) / Status : Reviewed
- The Asn-linked carbohydrate chains of human Tamm-Horsfall glycoprotein of one male. Novel sulfated and novel N-acetylgalactosamine-containing N-linked carbohydrate chains. (1992 - Hard K, Van Zadelhoff G, Moonen P, Kamerling J, Vliegenthart F) / Status : Reviewed
- Asparagine-linked oligosaccharide processing in lepidopteran insect cells. Temporal dependence of the nature of the oligosaccharides assembled on asparagine-289 of recombinant human plasminogen produced in baculovirus vector infected Spodoptera frugiperda (IPLB-SF-21AE) cells. (1991 - Davidson D, Castellino F) / Status : Reviewed
- Oligosaccharide structures present on asparagine-289 of recombinant human plasminogen expressed in a Chinese hamster ovary cell line. (1991 - Davidson D, Castellino F) / Status : Reviewed
- Isolation and structure determination of the intact sialylated N-linked carbohydrate chains of recombinant human follitropin expressed in Chinese hamster ovary cells. (1990 - Hard K, Mekking A, Damm J, Kamerling J, de Boer W, Wijnands R, Vliegenthart J) / Status : Reviewed
- The asparagine-linked sugar chains of plasma membrane glycoproteins of K-562 human leukaemic cells: a comparative study with human erythrocytes. (1982 - Yoshima H, Shiraishi N, Matsumoto A, Maeda S, Sugiyama T, Kobata A) / Status : Reviewed
Reference
- 4F2 cell-surface antigen heavy chain / Homo sapiens
- Aggrecan core protein / Homo sapiens
- Alpha-1-acid glycoprotein 1 / Homo sapiens
- Alpha-1-acid glycoprotein 2 / Homo sapiens
- Alpha-1-antichymotrypsin / Homo sapiens
- Apolipoprotein (a) / Homo sapiens
- Apolipoprotein d / Homo sapiens
-
Coagulation factor IX / Homo sapiens
- Undefined site
- Folate receptor alpha / Homo sapiens
-
Follitropin, alpha and beta chains / Homo sapiens
- Undefined site
- G-protein coupled receptor 126 / Homo sapiens
- Glucose-6-phosphate isomerase / Homo sapiens
- Haptoglobin / Homo sapiens
- Immunoglobulin heavy constant mu / Homo sapiens
-
Integrin alpha-5/beta-1 / Homo sapiens
- Undefined site
- Kallistatin / Homo sapiens
- Kininogen-1 / Homo sapiens
- Lysosomal acid lipase/cholesteryl ester hydrolase / Homo sapiens
- Lysosome-associated membrane glycoprotein 2 / Homo sapiens
- Multimerin-2 / Homo sapiens
- Nitrogen permease regulator 3-like protein / Homo sapiens
- Plasma protease c1 inhibitor / Homo sapiens
- Prostaglandin-h2 d-isomerase / Homo sapiens
- Receptor-type tyrosine-protein phosphatase F / Homo sapiens
-
Recombinant plasminogen - [r580e] / Homo sapiens
- Undefined site
-
Recombinant plasminogen - [r580s] / Homo sapiens
- Undefined site
-
Uncharacterized protein from Fluid / Homo sapiens
- Undefined site
- Uromodulin / Homo sapiens
- V-type proton ATPase subunit S1 / Mus musculus
-
Alpha-1-acid glycoprotein / Ovis aries
- Undefined site
-
Acetylcholine receptor protein / Torpedo californica
- Undefined site
- Recombinant Spike glycoprotein (HEK293) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
Reported glycosite
- LVPVPITNATLDR (13aa)
- LVPVPITNATLDQITGK (17aa)
- CIQANYSIMENGK (13aa)
- SVVAPATDGGLNLTSTFLR (19aa)
- MLFVEPILEVSSLPTTNSTTNSATK (25aa)
- SVQEIQATFFYFTPNK (16aa)
- SVQEIQATFFYFTPNK (16aa)
- YFTPNKTEDTIFLR (14aa)
- YFTPNKTEDTIFLR (14aa)
- SVQEIQATFFYFTPNKTEDTIFLR (24aa)
- SVQEIQATFFYFTPNKTEDTIFLR (24aa)
- QNQCFYNSSYLNVQR (15aa)
- QNQCFYNSSYLNVQR (15aa)
- INYTEGR (7aa)
- QDQCIYNTTYLNVQR (15aa)
- QDQCIYNTTYINVQR (15aa)
- ADGTVNQIEGEATPVNITEPAKIEVK (26aa)
- IAVQFGPGFSWIANFTK (17aa)
- FNLTETSEAEIHQSFQHLLR (20aa)
- SQILEGLGFNLTELSESDVHR (21aa)
- TQSLLIVNNATNVVIK (16aa)
- GWNWTSGFNK (10aa)
- YDIPASINFIINK (13aa)
- VYSSANNCTFE (11aa)
- HGIQYFNNNTQHSSLFTLNEVK (22aa)
- ALPGNLTAAVMEANQTGHEFPDR (23aa)
- CNTAAPMWLNGTHPSSDEGIVSR (23aa)
- DLPQGFSALEPLVDLPIGINITR (23aa)
- VVLHPNYSQVDIGLIK (16aa)
- YTGNASALFILPDQDKMEEVEAMLLPETLK (30aa)
- YTGNASALFILPDQDK (16aa)
- THTNISESHPNATFSAVGEASICEDDWNSGER (32aa)
- NGTITDAVDCALDPLSE (17aa)
- QDFNITDISLLEHR (14aa)
- LEIHSNGSVAHFNVSQVTGPSIYSFHCEYVSSVSK (35aa)
- IIIAGTNSSDIQQIISIIESNK (22aa)
- DNSSAELLPSGDSPLNQR (18aa)
- AGCLIGAEHVNNSYE (15aa)
- HVNNSYE (7aa)
- TVYLYPNQTGLPDPLSR (17aa)
- AGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPR (36aa)
- SLSSSSIGSNSTYLTSK (17aa)
- MLWEHNSTIIVMLTK (15aa)
- TPENYPNAGLTENYCR (16aa)
Mass spectrometry observed peptide
-
- N-Linked / Complex (avg mass : 3537.2137)
- Blood Serum (UBERON_0001977)
-
Alpha-1-acid glycoprotein 2 / Homo sapiens
- Undefined site
-
Alpha-1-acid glycoprotein / Ovis aries
- Undefined site
-
- N-Linked / Complex (avg mass : 3537.2137)
- Ovary (UBERON_0000992) Sf21 (CVCL_0518)
-
Recombinant plasminogen - [r580e] / Homo sapiens
- Undefined site
-
- N-Linked / Complex (avg mass : 3537.2137)
- Electric Organ (UBERON_0006869)
-
Acetylcholine receptor protein / Torpedo californica
- Undefined site
-
- N-Linked / Complex (avg mass : 3537.2137)
- Ovary (UBERON_0000992) CHO (CVCL_0213)
-
Recombinant plasminogen - [r580s] / Homo sapiens
- Undefined site
-
- N-Linked / Complex (avg mass : 3537.2137)
- Blood Serum (UBERON_0001977)
- Alpha-1-acid glycoprotein 1 / Homo sapiens
-
- N-Linked / Complex (avg mass : 3537.2137)
- Blood Plasma (UBERON_0001969)
-
Coagulation factor IX / Homo sapiens
- Undefined site
-
- N-Linked / Complex (avg mass : 3537.2137)
- Detailed oligosaccharide structures of human integrin alpha 5 beta 1 analyzed by a three-dimensional mapping technique. (1996 - Nakagawa H, Zheng M, Hakomori S, Tsukamoto Y, Kawamura Y, Takahashi N) / Status : Reviewed
- The Asn-linked carbohydrate chains of human Tamm-Horsfall glycoprotein of one male. Novel sulfated and novel N-acetylgalactosamine-containing N-linked carbohydrate chains. (1992 - Hard K, Van Zadelhoff G, Moonen P, Kamerling J, Vliegenthart F) / Status : Reviewed
- Isolation and structure determination of the intact sialylated N-linked carbohydrate chains of recombinant human follitropin expressed in Chinese hamster ovary cells. (1990 - Hard K, Mekking A, Damm J, Kamerling J, de Boer W, Wijnands R, Vliegenthart J) / Status : Reviewed
-
Follitropin, alpha and beta chains / Homo sapiens
- Undefined site
-
Integrin alpha-5/beta-1 / Homo sapiens
- Undefined site
-
Uromodulin / Homo sapiens
- Undefined site
-
- N-Linked / Complex (avg mass : 3537.2137)
- Urine (UBERON_0001088)
-
Uromodulin / Homo sapiens
- Undefined site
-
- N-Linked / Complex (avg mass : 3537.2137)
- Pleura (UBERON_0000977) K-562 (CVCL_0004)
- Leukemia, Myloid, Chronic (DOID:8552)
-
Uncharacterized protein from Fluid / Homo sapiens
- Undefined site
-
- Hex:7 HexNAc:6 NeuAc:4 / N-Linked (avg mass : 3537.2137)
- Blood Serum (UBERON_0001977)
- Brain (UBERON_0000955)
- Mammary Gland (UBERON_0001911)
- Urine (UBERON_0001088)
- HEK293 (CVCL_0045)
- N-Linked / Complex / Gal(b1-4)GlcNAc(?1-?)[Gal(b1-4)GlcNAc(?1-?)]Man(a1-?)[Gal(b1-4)GlcNAc(?1-?)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ Gal(b1-4)GlcNAc(?1-?) + 4 x NeuAc(a2-?)"
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-6)]Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ 2 x NeuAc(a2-3) + 2 x NeuAc(2-6)"
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-6)]Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ 4 x NeuAc"
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-6)]Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ 4 x NeuAc(a2-?)"
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-?)[Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-6)]Man(a1-?)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ 2 x NeuAc(a2-3) + 2 x NeuAc(a2-6)"
- N-Linked / Complex / Structure 775
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)[NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)[NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-6)]Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)[NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-6)]Man(a1-6)[NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-4)[NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)]Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / NeuAc(a2-?)Gal(b1-4)GlcNAc(b1-2)[NeuAc(a2-?)Gal(b1-4)GlcNAc(b1-6)]Man(a1-?)[NeuAc(a2-?)Gal(b1-4)GlcNAc(b1-4)[NeuAc(a2-?)Gal(b1-4)GlcNAc(b1-2)]Man(a1-?)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- Site-specific N-glycosylation Characterization of Recombinant SARS-CoV-2 Spike Proteins using High-Resolution Mass Spectrometry (2020 - Yong Zhang, Wanjun Zhao, Yonghong Mao, Shisheng Wang, Yi Zhong, Tao Su, Meng Gong, Xiaofeng Lu, Jingqiu Cheng, Hao Yang) / Status : Unreviewed
- Capturing site-specific heterogeneity with large-scale N-glycoproteome analysis (2019 - Nicholas M. Riley, Alexander S. Hebert, Michael S. Westphall & Joshua J. Coon ) / Status : Unreviewed
- Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein (2018 - Shisheng Sun, Yingwei Hu, Li Jia, Shadi Toghi Eshghi, Yang Liu, Punit Shah, Hui Zhang) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Large-scale intact glycopeptide identification by Mascot database search (2018 - Ravi Chand Bollineni, Christian Jeffrey Koehler, Randi Elin Gislefoss, Jan Haug Anonsen, Bernd Thiede) / Status : Unreviewed
- Distinct urinary glycoprotein signatures in prostate cancer patients (2018 - Rebeca Kawahara, Fabio Ortega, Livia Rosa-Fernandes, Vanessa Guimarães, Daniel Quina, Willian Nahas, Veit Schwämmle, Miguel Srougi, Katia R.M. Leite, Morten Thaysen-Andersen, Martin R. Larsen and Giuseppe Palmisano) / Status : Unreviewed
- Confident assignment of site-specific glycosylation in complex glycoproteins in a single step (2014 - Khatri K, Staples GO, Leymarie N, Leon DR, Turiák L, Huang Y, Yip S, Hu H, Heckendorf CF, Zaia J.) / Status : Reviewed
- 4F2 cell-surface antigen heavy chain / Homo sapiens
- Aggrecan core protein / Homo sapiens
- Alpha-1-acid glycoprotein 1 / Homo sapiens
- Alpha-1-acid glycoprotein 2 / Homo sapiens
- Alpha-1-antichymotrypsin / Homo sapiens
- Apolipoprotein (a) / Homo sapiens
- Apolipoprotein d / Homo sapiens
- Folate receptor alpha / Homo sapiens
- G-protein coupled receptor 126 / Homo sapiens
- Glucose-6-phosphate isomerase / Homo sapiens
- Haptoglobin / Homo sapiens
- Immunoglobulin heavy constant mu / Homo sapiens
- Kallistatin / Homo sapiens
- Kininogen-1 / Homo sapiens
- Lysosomal acid lipase/cholesteryl ester hydrolase / Homo sapiens
- Lysosome-associated membrane glycoprotein 2 / Homo sapiens
- Multimerin-2 / Homo sapiens
- Nitrogen permease regulator 3-like protein / Homo sapiens
- Plasma protease c1 inhibitor / Homo sapiens
- Prostaglandin-h2 d-isomerase / Homo sapiens
- Receptor-type tyrosine-protein phosphatase F / Homo sapiens
- Uromodulin / Homo sapiens
- V-type proton ATPase subunit S1 / Mus musculus
- Recombinant Spike glycoprotein (HEK293) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- LVPVPITNATLDR (13aa)
- LVPVPITNATLDQITGK (17aa)
- CIQANYSIMENGK (13aa)
- SVVAPATDGGLNLTSTFLR (19aa)
- MLFVEPILEVSSLPTTNSTTNSATK (25aa)
- SVQEIQATFFYFTPNK (16aa)
- SVQEIQATFFYFTPNK (16aa)
- YFTPNKTEDTIFLR (14aa)
- YFTPNKTEDTIFLR (14aa)
- SVQEIQATFFYFTPNKTEDTIFLR (24aa)
- SVQEIQATFFYFTPNKTEDTIFLR (24aa)
- QNQCFYNSSYLNVQR (15aa)
- QNQCFYNSSYLNVQR (15aa)
- INYTEGR (7aa)
- QDQCIYNTTYLNVQR (15aa)
- QDQCIYNTTYINVQR (15aa)
- ADGTVNQIEGEATPVNITEPAKIEVK (26aa)
- IAVQFGPGFSWIANFTK (17aa)
- FNLTETSEAEIHQSFQHLLR (20aa)
- SQILEGLGFNLTELSESDVHR (21aa)
- TQSLLIVNNATNVVIK (16aa)
- GWNWTSGFNK (10aa)
- YDIPASINFIINK (13aa)
- VYSSANNCTFE (11aa)
- HGIQYFNNNTQHSSLFTLNEVK (22aa)
- ALPGNLTAAVMEANQTGHEFPDR (23aa)
- CNTAAPMWLNGTHPSSDEGIVSR (23aa)
- DLPQGFSALEPLVDLPIGINITR (23aa)
- VVLHPNYSQVDIGLIK (16aa)
- YTGNASALFILPDQDKMEEVEAMLLPETLK (30aa)
- YTGNASALFILPDQDK (16aa)
- THTNISESHPNATFSAVGEASICEDDWNSGER (32aa)
- NGTITDAVDCALDPLSE (17aa)
- QDFNITDISLLEHR (14aa)
- LEIHSNGSVAHFNVSQVTGPSIYSFHCEYVSSVSK (35aa)
- IIIAGTNSSDIQQIISIIESNK (22aa)
- DNSSAELLPSGDSPLNQR (18aa)
- AGCLIGAEHVNNSYE (15aa)
- HVNNSYE (7aa)
- TVYLYPNQTGLPDPLSR (17aa)
- AGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPR (36aa)
- SLSSSSIGSNSTYLTSK (17aa)
- MLWEHNSTIIVMLTK (15aa)
- TPENYPNAGLTENYCR (16aa)
Source
Suggested structure
Reference
Reported glycosite
Mass spectrometry observed peptide
Source
Disease
Reported glycosite
Source
Disease
Reported glycosite
Disease
Reference
Reported glycosite
Source
Disease
Reported glycosite
Source
Disease
Reported glycosite
Source
Disease
Reported glycosite
Source
Disease
Reported glycosite
Source
Disease
Reported glycosite
Source
Disease
Reported glycosite
